Clinical Trials Directory

Trials / Unknown

UnknownNCT03766633

Accuracy of the LiverVision® Semi-automated Liver Volumetry Software

Accuracy of Established Manual Versus New Semi-automated Liver Volumetry Software in Patients Undergoing Living Donor Liver Transplantation

Status
Unknown
Phase
Study type
Observational
Enrollment
108 (estimated)
Sponsor
Royal Free Hospital NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The LiverVision® software was designed to provide three-dimensional (3D) visualisation of the liver using Computed Tomography (CT) scans. It provides semi-automated volumetry measurements, vascular structure and territory tools.

Detailed description

Liver volumetry has been widely used in liver surgery and living donor liver transplantation to estimate the future liver remnant or the required liver volume for the recipient, respectively. Liver volumetry is typically performed using CT imaging with specially designed software. Such manual measurements are time consuming and there is an ongoing debate whether the they reflect the actual liver volume when performed by radiologists or surgeons as well as according to the different software currently available in the market.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLiver volumetry of the graft on CTPreoperative liver volumetry using the CT images of the potential living liver donors.

Timeline

Start date
2018-04-29
Primary completion
2021-03-31
Completion
2021-03-31
First posted
2018-12-06
Last updated
2020-11-20

Locations

3 sites across 3 countries: Germany, Turkey (Türkiye), United Kingdom

Source: ClinicalTrials.gov record NCT03766633. Inclusion in this directory is not an endorsement.

Accuracy of the LiverVision® Semi-automated Liver Volumetry Software (NCT03766633) · Clinical Trials Directory